An interventional study of LI4 Acupuncture and Sham Acupuncture in Pain Associated With Intrauterine Device Insertion, sponsored by Nigde Omer Halisdemir University. Recruiting at 1 site in Turkey (Türkiye). Open to female participants aged 18 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-18.
Sponsored by Nigde Omer Halisdemir University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 81 studies in Pain, Procedural with a site in Turkey — 14 open to participants now, 14 under way, none of them phase 3. Pain, Procedural · Turkey.
Among the 81 studies in Pain, Procedural with a site in Turkey, this one is the 12th largest by planned enrollment of the 79 interventional ones that give a count, is one of 20 that started in 2026, is one of 77 with no phase, reaches primary completion later than 13 of the 13 other live ones, and was the 73rd registered.
246 studies on the registry are indexed under Pain, Procedural; 66 are open to participants now.
Browse Pain, Procedural studies →14 of the 81 studies in Pain, Procedural with a site in Turkey are open now. Recruiting first, the newest first:
TC Erciyes University · Sites in Turkey
Ages 18+ · Women only
Akdeniz University · Sites in Turkey
Ages 6–12 · Healthy volunteers
Mersin University · Sites in Turkey
Ages 4–7
Marmara University · Sites in Turkey
Ages 2 days–7 days · Healthy volunteers
Baskent University · Sites in Turkey
Ages 1 days–28 days · Healthy volunteers
A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →
Of the 30 Pain, Procedural studies recruiting now, 13 (43%) set no upper age limit and 15 (50%) stop at 75 or younger; 14 take children under 18; 6 take healthy volunteers.
This study: 18 Years to 50 Years · female · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
81 studies; the count open now beside each. This study's row is marked.
First in 2013; this study’s year is marked. 20 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 150 is above the median of 90 across 232 interventional studies indexed under Pain, Procedural.
Median enrollment 100 across the 79 interventional studies, 140 across the 2 observational. Of the 65 that completed or were terminated, 2 (3%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 81 has an industry lead sponsor. The 10 most frequent:
Nigde Omer Halisdemir University is the lead sponsor of 95 studies on the registry; 32 are open to participants now.
Nigde Omer Halisdemir University has 1 study filed under Pain, Procedural — fewer than ten, so there is no comparison to draw.
7 of the studies in Pain, Procedural with a site in Turkey that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07916064Ankara Etlik City HospitalEffect of Ketamine on Optic Nerve Sheath Diameter During Procedural Analgesia | 2026-12-15 |
| NCT07930962Bulent Ecevit UniversityThe Effectiveness of Wearable Technology-Supported Gamification in Reducing Pain and Anxiety During Medical Procedures in Children: A Randomized Controlled Trial | 2026-12-30 |
| NCT07761689Marmara UniversityThe Effect of Kangaroo Care on Pain in Infants Receiving Phototherapy | 2026-12-30 |
| NCT07906834Samsun UniversityEffect of Short-Video Distraction During Burn Dressing on Anxiety, Pain, and Fear in Children | 2027-02 |
| NCT07907679Tarsus UniversityVirtual Reality for Pain and Anxiety During Surgical Uterine Evacuation After Early Pregnancy Loss | 2027-04-30 |
Add all 7 to your calendar (.ics) → With an account.
Among the 81 studies in Pain, Procedural with a site in Turkey, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study will evaluate whether acupuncture can reduce pain during intrauterine device (IUD) insertion. Women undergoing IUD insertion will be randomly assigned to receive either real acupuncture at the LI4 point on both hands or a sham acupuncture procedure that does not penetrate the skin. Both interventions will be applied for 15 minutes before IUD insertion. Participants will not know which treatment they receive. The clinician performing the IUD insertion and the researcher assessing the outcomes will also be unaware of the treatment assignment. Pain will be measured at different stages of the IUD insertion procedure and shortly after the procedure. The main outcome will be the highest pain score reported during IUD insertion. The study will also assess procedure tolerance, patient satisfaction, need for additional pain medication, and adverse events.
Pain during intrauterine device (IUD) insertion may affect procedure tolerance and patients' experience with this highly effective contraceptive method. Although several pharmacological approaches have been investigated for pain control during IUD insertion, their effectiveness has been inconsistent, and there is no universally accepted analgesic approach.
LI4 (Hegu) is an acupuncture point commonly used for analgesia. In a previous randomized controlled trial conducted by the investigators, bilateral LI4 acupuncture before IUD insertion was associated with lower post-procedural pain scores compared with no intervention. However, the absence of a sham control in that study did not allow specific effects of acupuncture to be distinguished from placebo and other nonspecific effects.
The present randomized, sham-controlled trial is therefore designed to evaluate the analgesic effect of bilateral LI4 acupuncture using a non-penetrating Park sham procedure as the comparator. The primary focus is pain experienced during the IUD insertion procedure. The sham-controlled and masked design is intended to reduce expectancy and assessment bias and provide a more rigorous estimate of the effect of LI4 acupuncture on procedure-related pain.
The IUD insertion procedure will be standardized across both study groups. No routine analgesic premedication will be administered before the procedure. IUD insertion will be performed according to the same standardized clinical protocol in all participants, including speculum placement, visualization of the cervix, tenaculum application, measurement of the uterine cavity, and IUD insertion. No analgesic medication will be routinely administered during the procedure. After completion of the scheduled pain assessments, an NSAID may be administered as rescue analgesia if clinically required, and its use will be recorded. Apart from the assigned acupuncture or sham acupuncture intervention, procedural management will be identical between the two groups.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.
Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.
Contraception
Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.
Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Hypersensitivity
An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants assigned to this arm will receive bilateral acupuncture at the LI4 (Hegu) point 15 minutes before IUD insertion. Sterile 0.25 × 25 mm acupuncture needles will be inserted to a depth of approximately 1.5-2 cm. Manual stimulation will be applied to elicit de qi. The needles will remain in place for 15 minutes and will be removed before the IUD insertion procedure.
Procedure: LI4 Acupuncture
Participants assigned to this arm will receive bilateral sham acupuncture at the LI4 (Hegu) point using Park-type non-penetrating sham needles 15 minutes before IUD insertion. The sham needles will not penetrate the skin, and no de qi or manual stimulation will be elicited. The sham procedure will last 15 minutes and will be completed before the IUD insertion procedure, with the duration of treatment and participant-practitioner interaction standardized to match the LI4 acupuncture arm.
Procedure: Sham Acupuncture
Bilateral acupuncture will be performed at the LI4 (Hegu) point 15 minutes before IUD insertion using sterile 0.25 × 25 mm acupuncture needles. Needles will be inserted to a depth of approximately 1.5-2 cm, and manual stimulation will be applied to elicit de qi. The needles will remain in place for 15 minutes and will then be removed before the IUD insertion procedure.
Bilateral sham acupuncture will be performed at the LI4 (Hegu) point 15 minutes before IUD insertion using Park-type non-penetrating sham needles. The sham needles will not penetrate the skin, and no de qi or manual stimulation will be elicited. The sham procedure will last 15 minutes and will be completed before IUD insertion. Treatment duration and participant-practitioner interaction will be standardized to match the LI4 acupuncture intervention.
Maximum Procedure-Related Pain During IUD Insertion
Pain will be assessed using a 10-cm Visual Analog Scale (VAS), ranging from 0 (no pain) to 10 (worst imaginable pain), at three predefined procedural stages: tenaculum application, passage through the uterine cavity, and fundal placement of the IUD. For each participant, the highest VAS score recorded across these three stages will be defined as the maximum procedure-related pain score. Higher scores indicate greater pain.
Time frame: During the IUD insertion procedure
Pain During Tenaculum Application
Pain will be assessed using a 10-cm Visual Analog Scale (VAS), ranging from 0 (no pain) to 10 (worst imaginable pain), during tenaculum application. Higher scores indicate greater pain.
Time frame: During tenaculum application
Pain During Passage Through the Uterine Cavity
Pain will be assessed using a 10-cm Visual Analog Scale (VAS), ranging from 0 (no pain) to 10 (worst imaginable pain), during passage through the uterine cavity. Higher scores indicate greater pain.
Time frame: During passage through the uterine cavity
Pain During Fundal Placement of the IUD
Pain will be assessed using a 10-cm Visual Analog Scale (VAS), ranging from 0 (no pain) to 10 (worst imaginable pain), during fundal placement of the IUD. Higher scores indicate greater pain.
Time frame: During fundal placement of the IUD
Pain at 3 Minutes After IUD Insertion
Pain will be assessed using a 10-cm Visual Analog Scale (VAS), ranging from 0 (no pain) to 10 (worst imaginable pain). Higher scores indicate greater pain.
Time frame: 3 minutes after completion of IUD insertion
Pain at 10 Minutes After IUD Insertion
Pain will be assessed using a 10-cm Visual Analog Scale (VAS), ranging from 0 (no pain) to 10 (worst imaginable pain). Higher scores indicate greater pain.
Time frame: 10 minutes after completion of IUD insertion
Occurrence of Vasovagal Reaction
Occurrence of a clinically observed vasovagal reaction associated with the IUD insertion procedure will be recorded as yes or no.
Time frame: During IUD insertion and through 10 minutes after the procedure
Use of Rescue Analgesia
The need for rescue analgesic medication related to pain during or immediately after the IUD insertion procedure will be recorded as yes or no.
Time frame: During IUD insertion and through 10 minutes after the procedure
Procedure Tolerance
Participants will rate their overall tolerance of the IUD insertion procedure using an 11-point numerical rating scale ranging from 0 (completely intolerable) to 10 (completely tolerable). Higher scores indicate better procedure tolerance.
Time frame: 10 minutes after completion of IUD insertion
Patient Satisfaction
Participants will rate their overall satisfaction with the IUD insertion experience using an 11-point numerical rating scale ranging from 0 (not at all satisfied) to 10 (completely satisfied). Higher scores indicate greater satisfaction.
Time frame: 10 minutes after completion of IUD insertion
Willingness to Choose the Same Method Again
Participants will be asked whether they would choose the same contraceptive method again based on their current IUD insertion experience. Responses will be recorded as yes or no.
Time frame: 10 minutes after completion of IUD insertion
Pain Compared With Preprocedural Expectation
Participants will be asked to compare the pain experienced during IUD insertion with the pain they expected before the procedure. Responses will be categorized as less painful than expected, approximately as painful as expected, or more painful than expected.
Time frame: 10 minutes after completion of IUD insertion
Acupuncture-Related Adverse Events
Adverse events potentially related to the acupuncture or sham acupuncture intervention will be assessed, including local pain, minor bleeding, hematoma, and dizziness. The occurrence of one or more of these events will be recorded for each participant.
Time frame: From initiation of the acupuncture or sham procedure through 10 minutes after IUD insertion
Participant Blinding Assessment
Participants will be asked to indicate which intervention they believe they received. Response options will be: real acupuncture, sham acupuncture, or do not know. The distribution of responses will be compared between randomized groups to assess the success of participant blinding.
Time frame: 10 minutes after completion of IUD insertion, after completion of the other outcome assessments
Plan to share: Yes — Deidentified individual participant data underlying the results reported in the published article may be shared upon reasonable request to the corresponding author, following publication of the study results and subject to approval of the proposed use and applicable ethical and institutional requirements.
Supporting information: Study protocol, Statistical analysis plan
Time frame: Beginning 6 months after publication of the study results and available for 5 years thereafter.
Access criteria: Deidentified individual participant data underlying the results reported in the published article, together with the study protocol, statistical analysis plan, and analytic code, will be available to qualified researchers upon reasonable request to the corresponding author. Requests should include a scientifically sound research proposal and a description of the intended use of the data. Access will be subject to approval by the study investigators and applicable ethical and institutional requirements. Data will be provided through a secure data-sharing method following approval.
No publications or documents are linked to this record.
Started Nov 2026 (actual). Primary completion is estimated for Jul 2027, 7 months after the start.
Of 145 non-industry interventional studies with no phase under Pain, Procedural, half reached primary completion within 7 months of starting (the median), counting those still running; a quarter within 3 and three quarters within 15. This study's planned 7 months is close to that.
Counting every sponsor, half of 145 studies reached it within 7 months; a quarter within 3 and three quarters within 15.
Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 18, 2026: start Oct 2026 → Nov 2026, primary completion May 2027 → Jul 2027 and completion May 2027 → Jul 2027.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Nigde Omer Halisdemir University